TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

BACKGROUND: The highly refractory nature of non-small cell lung cancer (NSCLC) to chemotherapeutic drugs is an important factor resulting in its poor prognosis. Recent studies have revealed that tumour necrosis factor alpha-induced protein 8 (TNFAIP8) is involved in various biological and pathologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Ying, Liu, Yuechao, Liu, Tianbo, Meng, Qingwei, Lu, Hailing, Liu, Wei, Hu, Jing, Li, Chunhong, Cao, Mengru, Yan, Shi, Huang, Jian, Wang, Ting, Cai, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069800/
https://www.ncbi.nlm.nih.gov/pubmed/30064446
http://dx.doi.org/10.1186/s12964-018-0254-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069800/
https://www.ncbi.nlm.nih.gov/pubmed/30064446
http://dx.doi.org/10.1186/s12964-018-0254-x

Ejemplares similares